Brainify.AI Company
AI/ML EEG biomarker platform for novel treatment development for depression in women, which increases the likelihood of new drug approval.
Founded Date:
2021-02-27
Technology:
['BioTech & HealthTech']
Investor Type:
info@brainify.ai
Funding Status:
Seed
Total Funding:
1600000
Employee Number:
11-50
Headquarters:
New York, New York, United States
Last Funding Date:
2023-01-10
Last Funding Type:
Pre-Seed
Industry:
NeuroTech